Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Development Opportunities In Untapped Emerging Markets
3.1.2. Increased Adoption Of Pharmaceutical Continuous Manufacturing Systems
3.1.3. Rising Government Initiatives For The Adoption Of Continuous Manufacturing Systems
3.1.4. Rise In Production Of Large Molecules And Biologics
3.1.5. Increase In The Healthcare Expenditure
3.2. Key Restraints
3.2.1. Increasing Customer Anticipations
3.2.2. Lack Of Demand For Continuous Manufacturing Systems In Underdeveloped Countries

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Pharmaceutical Continuous Manufacturing Market
4.3. Regulatory Framework
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Product
5.1. Integrated Continuous System
5.2. Semi-Continuous System
5.3. Control & Software

6. Market By Application
6.1. Final Drug Product Manufacturing
6.2. Api Manufacturing

7. Market By End-User
7.1. Pharmaceutical Companies
7.2. Contract Manufacturing Organizations
7.3. Other End-Users

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.2. Canada
8.2. Europe
8.2.1. Market Size & Estimates
8.2.2. Key Growth Enablers
8.2.3. Key Challenges
8.2.4. Key Players
8.2.5. Country Analysis
8.2.5.1. Germany
8.2.5.2. France
8.2.5.3. United Kingdom
8.2.5.4. Italy
8.2.5.5. Russia
8.2.5.6. Belgium
8.2.5.7. Poland
8.2.5.8. Rest Of Europe
8.3. Asia Pacific
8.3.1. Market Size & Estimates
8.3.2. Key Growth Enablers
8.3.3. Key Challenges
8.3.4. Key Players
8.3.5. Country Analysis
8.3.5.1. China
8.3.5.2. India
8.3.5.3. Japan
8.3.5.4. Australia & New Zealand
8.3.5.5. South Korea
8.3.5.6. Thailand
8.3.5.7. Indonesia
8.3.5.8. Vietnam
8.3.5.9. Rest Of Asia Pacific
8.4. Rest Of World
8.4.1. Market Size & Estimates
8.4.2. Key Growth Enabler
8.4.3. Key Challenge
8.4.4. Key Players
8.4.5. Regional Analysis
8.4.5.1. Latin America
8.4.5.2. Middle East & Africa

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Merger & Acquisitions
9.1.2. Product Launch & Developments
9.1.3. Partnership, Contract/Agreement & Collaboration
9.1.4. Business Expansion/ Approval/ Announcement
9.2. Company Profile
9.2.1. Coperion Gmbh
9.2.2. Eli Lilly & Company
9.2.3. Gea Group Ag
9.2.4. Gebruder Lodige Maschinenbau Gmbh
9.2.5. Glatt Gmbh
9.2.6. Hosokawa Micron Corporation
9.2.7. Korsch Ag
9.2.8. Lb Bohle Maschinen + Verfahren Gmbh
9.2.9. Munson Machinery Company
9.2.10. Pfizer Inc
9.2.11. Siemens Healthineers
9.2.12. Syntegon (Formerly Bosch Packaging Technology)
9.2.13. Thermo Fisher Scientific Inc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Global Pharmaceutical Continuous Manufacturing Market, By Product, In 2020
Figure 6: Global Pharmaceutical Continuous Manufacturing Market, By Integrated Continuous System, 2021-2028 (In $ Million)
Figure 7: Global Pharmaceutical Continuous Manufacturing Market, By Semi-Continuous System, 2021-2028 (In $ Million)
Figure 8: Global Pharmaceutical Continuous Manufacturing Market, By Control & Software, 2021-2028 (In $ Million)
Figure 9: Global Pharmaceutical Continuous Manufacturing Market, By Application, In 2020
Figure 10: Global Pharmaceutical Continuous Manufacturing Market, By Final Drug Product Manufacturing, 2021-2028 (In $ Million)
Figure 11: Global Pharmaceutical Continuous Manufacturing Market, By Api Manufacturing, 2021-2028 (In $ Million)
Figure 12: Global Pharmaceutical Continuous Manufacturing Market, By End-User, In 2020
Figure 13: Global Pharmaceutical Continuous Manufacturing Market, By Pharmaceutical Companies, 2021-2028 (In $ Million)
Figure 14: Global Pharmaceutical Continuous Manufacturing Market, By Contract Manufacturing Organizations, 2021-2028 (In $ Million)
Figure 15: Global Pharmaceutical Continuous Manufacturing Market, By Other End-Users, 2021-2028 (In $ Million)
Figure 16: North America Pharmaceutical Continuous Manufacturing Market, Country Outlook, 2020 & 2028 (In %)
Figure 17: United States Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 18: Canada Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 19: Europe Pharmaceutical Continuous Manufacturing Market, Country Outlook, 2020 & 2028 (In %)
Figure 20: Germany Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 21: France Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 22: United Kingdom Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 23: Italy Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 24: Russia Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 25: Belgium Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 26: Poland Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 27: Rest Of Europe Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 28: Asia Pacific Pharmaceutical Continuous Manufacturing Market, Country Outlook, 2020 & 2028 (In %)
Figure 29: China Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 30: India Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 31: Japan Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 32: Australia & New Zealand Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 33: South Korea Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 34: Thailand Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 35: Indonesia Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 36: Vietnam Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 37: Rest Of Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 38: Rest Of World Pharmaceutical Continuous Manufacturing Market, Regional Outlook, 2020 & 2028 (In %)
Figure 39: Latin America Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)
Figure 40: Middle East & Africa Pharmaceutical Continuous Manufacturing Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL CONTINUOUS MANUFACTURING
TABLE 2: PROJECTED NATIONAL HEALTHCARE EXPENDITURE, 2021-2028 (IN $ BILLION)
TABLE 3: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL INTEGRATED CONTINUOUS SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: GLOBAL INTEGRATED CONTINUOUS SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL SEMI-CONTINUOUS SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: GLOBAL SEMI-CONTINUOUS SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL CONTROL & SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 10: GLOBAL CONTROL & SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 12: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL FINAL DRUG PRODUCT MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 14: GLOBAL FINAL DRUG PRODUCT MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL API MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: GLOBAL API MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 19: GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: GLOBAL PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 21: GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 22: GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 23: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 24: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 25: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: LEADING PLAYERS OPERATING IN NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
TABLE 30: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: LEADING PLAYERS OPERATING IN EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
TABLE 33: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: LEADING PLAYERS OPERATING IN ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
TABLE 36: REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: LEADING PLAYERS OPERATING IN REST OF WORLD PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET